Organizational chart

Organigram Announces Appointment of Karina Gehring to Board of Directors

Retrieved on: 
Friday, January 19, 2024
Alternative Medicine, Health, Natural Resources, Cannabis, Organizational chart, Chairperson, OGI, Investment, Multimedia, BAT, British American Tobacco, American Tobacco Company, TSX, Marketing

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), announced the appointment of Karina Gehring to the Organigram Board of Directors at the Company’s annual general and special meeting held on January 18, 2024.

Key Points: 
  • Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), announced the appointment of Karina Gehring to the Organigram Board of Directors at the Company’s annual general and special meeting held on January 18, 2024.
  • View the full release here: https://www.businesswire.com/news/home/20240119151071/en/
    “We are thrilled to welcome Karina to our Board of Directors.
  • Her extensive expertise in marketing and brand management combined with her ongoing experience with BAT will be a tremendous asset to our Board,” said Peter Amirault, Board Chair, Organigram.
  • Karina is one of two directors (including Simon Ashton) designated by BT DE Investments Inc., a wholly owned subsidiary of British American Tobacco plc (“BAT”), as nominees to the Company’s Board.

Organigram Announces Appointment of Greg Guyatt as Chief Financial Officer

Retrieved on: 
Monday, December 18, 2023
Cannabis, Natural Resources, Interim, BAT, Sears Canada, Multimedia, OGI, TSX, Management, Organizational chart, Jupiter

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) is pleased to announce that Greg Guyatt CPA, CA, formerly of Phoena Holdings Inc. (“Phoena”), has been appointed to the role of Chief Financial Officer effective January 8, 2024.

Key Points: 
  • Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) is pleased to announce that Greg Guyatt CPA, CA, formerly of Phoena Holdings Inc. (“Phoena”), has been appointed to the role of Chief Financial Officer effective January 8, 2024.
  • Mr. Guyatt will lead Organigram’s Finance and IT divisions and will report directly to Beena Goldenberg, Organigram’s Chief Executive Officer.
  • He joined Phoena as Chief Financial Officer in 2019 before assuming the position of Chief Executive Officer in 2020.
  • Prior to joining Phoena, Mr. Guyatt was Chief Financial Officer of Greenspace Brands and held various progressive senior finance positions at Kingsett Capital and Sears Canada.

Organigram Wins KIND Magazine’s Innovation of the Year for SHRED X Rip-Strips Hash

Retrieved on: 
Wednesday, December 13, 2023
Alternative Medicine, Cannabis, Retail, Health, Natural Resources, Specialty, Food, Beverage, Edible, Organizational chart, Creativity, Multimedia, OGI, Innovation, TSX, KIND, Thomas Edison

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of a leading licensed producer of cannabis (the “Company” or “Organigram”), is thrilled to announce it has won KIND Magazine’s (“KIND”) Innovation of the Year award for its revolutionary SHRED X Rip-Strips Hash.

Key Points: 
  • Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of a leading licensed producer of cannabis (the “Company” or “Organigram”), is thrilled to announce it has won KIND Magazine’s (“KIND”) Innovation of the Year award for its revolutionary SHRED X Rip-Strips Hash.
  • This is the second time Organigram has won this coveted award, having previously won for the Company’s patented Edison JOLTS ingestible extract product.
  • View the full release here: https://www.businesswire.com/news/home/20231213515729/en/
    “We are very proud to be recognized by KIND Magazine once again for our outstanding achievements in innovation,” says Beena Goldenberg, CEO, Organigram.
  • “A huge congratulations to Organigram for winning their second Innovation of the Year award in the last two years – first with Edison JOLTS, and now with the incredibly innovative SHRED X Rip-Strips Hash,” said Joshua Nagel, Founder & Chief Dream Officer at KIND.

Organigram Increases Investment in Phylos After Successful Milestone Achievement

Retrieved on: 
Tuesday, November 28, 2023
Professional Services, Cannabis, Retail, Specialty, Finance, Natural Resources, Cannabinoid, Senior, Convertible, Seed, Trailblazer, Loan agreement, Multimedia, THCV, CBDV, OGI, Initial, CBC, PIK, Breeding, R, THCP, Innovation, TSX, Loan, CBG, Security (finance), Organizational chart, Phylo (polychaete), Citrus

This second tranche follows the initial tranche of US$3.25 million advanced in May 2023 for a total of US$6 million in senior secured convertible loans (“Convertible Loans”) currently outstanding.

Key Points: 
  • This second tranche follows the initial tranche of US$3.25 million advanced in May 2023 for a total of US$6 million in senior secured convertible loans (“Convertible Loans”) currently outstanding.
  • View the full release here: https://www.businesswire.com/news/home/20231128416832/en/
    Organigram’s ongoing trials using Phylos technology have resulted in highly-uniform, predictable, and fast-growing seedlings.
  • Our investment in Phylos was driven by that commitment, and we are thrilled with the progress we have made and the benefits we are reaping from this strategic investment,” says Borna Zlamalik, Senior Vice President, R&D and Innovation at Organigram.
  • In August, Organigram launched its first lineup of whole-flower derived THCV products through the Company’s popular SHRED and newly re-launched Trailblazer brands enabled by the strategic investment in Phylos.

Organigram Announces Interim Chief Financial Officer

Retrieved on: 
Friday, November 10, 2023
Natural Resources, Alternative Medicine, Health, Tobacco, Specialty, Food, Beverage, Cannabis, Retail, OGI, ERP, TSX, CFO, Organizational chart

The Board of Directors (the “Board”) of Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) today announced that Derrick West has informed Organigram that he will transition away from his role as Chief Financial Officer (“CFO”) in order to take time to focus on his health and recovery following surgery later this month.

Key Points: 
  • The Board of Directors (the “Board”) of Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) today announced that Derrick West has informed Organigram that he will transition away from his role as Chief Financial Officer (“CFO”) in order to take time to focus on his health and recovery following surgery later this month.
  • Paolo De Luca, current Chief Strategy Officer, has been appointed interim CFO effective November 13, 2023, while the Company completes a search for a new permanent CFO.
  • “Derrick has left a legacy of stabilizing our financial processes along with the implementation of our ERP and has supported the Company through a period of high growth including the acquisitions of our Winnipeg and Lac-Supérieur facilities,” said Ms. Goldenberg, CEO of Organigram.
  • “We are grateful for his contributions during his time on the board beginning in 2017 and since becoming CFO in 2020 and we wish him well.”

Organigram Announces C$124.6 Million Investment from BAT and Creation of “Jupiter” Strategic Investment Pool

Retrieved on: 
Monday, November 6, 2023
Cannabis, Natural Resources, Other Retail, Retail, Specialty, The Competition Act, 2002, Competition Act, NYSE, Development, Multilateral, Minority, BAT, Investment, MI, EBITDA, IRA, Acquisition, Multimedia, Growth, Indian stock exchange, PDC, Partnership, LSE, Emulsion, BTI, Edible, OGI, THCV, Calendar, TSX, Renewable energy, Drug, Security (finance), Organizational chart

In addition, this deepens the strategic partnership between Organigram and BAT, and we look forward to continuing to leverage BAT’s global capabilities and scientific expertise,” said Beena Goldenberg, CEO of Organigram.

Key Points: 
  • In addition, this deepens the strategic partnership between Organigram and BAT, and we look forward to continuing to leverage BAT’s global capabilities and scientific expertise,” said Beena Goldenberg, CEO of Organigram.
  • Through this investment, Organigram aims to capitalize on its state-of-the-art facilities, support further workstreams in R&D and product development and deliver impactful product launches.
  • The majority of the C$124.6 million investment will be used by Organigram to create a strategic investment pool, named Jupiter.
  • Additional information regarding the Investment will be included in a material change report to be filed by Organigram on www.sedarplus.ca .

Organigram Provides Corporate Update

Retrieved on: 
Wednesday, October 18, 2023
Alternative Medicine, Cannabis, Retail, Health, Tobacco, Natural Resources, Food, Beverage, F1 hybrid, BAT, Lac, Energy, NB Power, Organizational chart, Edible, Partnership, NB, THC, ERP, Silviculture, Phylo (video game)

Investment and Collaboration with U.S. Based Phylos Biosciences

Key Points: 
  • Investment and Collaboration with U.S. Based Phylos Biosciences
    Monetizing the investment in Phylos Bioscience continues to be a key focus as Organigram moves towards seed-based production in its Moncton facility.
  • This investment in automated pre-roll technology has helped Organigram secure the #2 position in the category.
  • Clones are now onsite, and Organigram expects to see the first harvest out of that facility by early December.
  • As previously disclosed, Organigram has recently changed its fiscal year end to better reflect its operating and financial cycles.

Organigram Holdings Inc. Files Final Base Shelf Prospectus

Retrieved on: 
Thursday, October 12, 2023
Cannabis, Natural Resources, Organizational chart, TSX, Registration statement, Form, OGI, Register, Security (finance)

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licenced producer of cannabis, announced today that it has obtained a receipt for a final short form base shelf prospectus (the “Base Shelf Prospectus”) filed with the securities commissions in each of the provinces and territories of Canada.

Key Points: 
  • Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licenced producer of cannabis, announced today that it has obtained a receipt for a final short form base shelf prospectus (the “Base Shelf Prospectus”) filed with the securities commissions in each of the provinces and territories of Canada.
  • A corresponding shelf registration statement on Form F-10 (the “Registration Statement”) has been filed with the United States Securities and Exchange Commission (SEC File No.
  • The Base Shelf Prospectus enables Organigram to qualify the distribution of up to C$500,000,000 of common shares, debt securities, subscription receipts, warrants, and units during the 25-month period that the Base Shelf Prospectus remains effective.
  • The Base Shelf Prospectus will provide flexibility for financing options to pursue the Company’s objectives.

Organigram Holdings Inc. Files Preliminary Base Shelf Prospectus

Retrieved on: 
Tuesday, September 26, 2023
Cannabis, Natural Resources, Exchange, Register, Organizational chart, OGI, Form, TSX, Registration statement, Security (finance)

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licenced producer of cannabis, announced today that it has filed a preliminary short form base shelf prospectus (the “Base Shelf Prospectus”) with the securities commissions in each of the provinces and territories of Canada.

Key Points: 
  • Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licenced producer of cannabis, announced today that it has filed a preliminary short form base shelf prospectus (the “Base Shelf Prospectus”) with the securities commissions in each of the provinces and territories of Canada.
  • A corresponding shelf registration statement on Form F-10 (the “Registration Statement”) has been filed with the United States Securities and Exchange Commission but is not yet effective.
  • The Base Shelf Prospectus, when made final and effective, will allow Organigram to qualify the distribution of up to C$500,000,000 of common shares, debt securities, subscription receipts, warrants, and units during the 25-month period that the Base Shelf Prospectus remains effective.
  • The Base Shelf Prospectus when final and effective, will provide flexibility for financing options to pursue the Company’s objectives.

Organigram Announces Resignation of Board Member

Retrieved on: 
Friday, September 1, 2023
Cannabis, Natural Resources, BAT, Strategic planning, Assistant, Bat, OGI, TSX, Management, Organizational chart

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announces today that Ms. Caroline Ferland has resigned from the Board of Directors (“the Board”) effective immediately.

Key Points: 
  • Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announces today that Ms. Caroline Ferland has resigned from the Board of Directors (“the Board”) effective immediately.
  • Ms. Ferland was a board member nominee appointed by BAT.
  • “In her short time on the Board, Ms. Ferland made considerable contributions to Organigram,” said Peter Amirault, Chair of Organigram’s Board of Directors.
  • The Board of Directors and the Company’s management team would like to thank Ms. Ferland for her valuable contributions to Organigram and wish her well in her new role.